A simple tool to evaluate common disorders: validation of a “proctological symptom scale” by unknown
ORIGINAL ARTICLE
A simple tool to evaluate common disorders: validation
of a Bproctological symptom scale^
Matthias Kraemer & David Kara & Michael Rzepisko &
Joel Sayfan
Accepted: 9 February 2015 /Published online: 20 February 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Purpose Proctological symptomatology is of little complexity
and therefore appears particularly suitable for comparative
evaluation by visual scales. We devised a Bproctological
symptom scale^ (PSS) with separate scales for four cardinal
proctological symptoms: pain, itching/irritation, discharge/
moisture, and bleeding. The objective of this study was to
evaluate the PSS among proctological patients and non-
proctological controls.
Methods This was a single center non-interventional observa-
tional study on 229 proctological patients and 133 controls.
The main outcome measures investigated were age- and sex-
stratified comparison of the non-proctological cohort and the
controls, effect of therapeutic intervention on scale values in a
subset of patients with haemorrhoidal disease, and sensitivity
of the PSS to detect therapeutic failure in this subset of
patients.
Results The PSS was found to significantly differentiate be-
tween proctological patients and controls. Gender and age had
no significant influence on PSS values in the proctological
cohort. The intervention (one session of rubber band ligation
in patients with haemorrhoidal disease) was reflected by a
significantly improved overall PSS. In 16 cases within this
group, the PSS got worse. A case-by-case follow-up of these
patients showed that 14 of the 16 patients ended up with sur-
gery (or with the advice to have surgery).
Conclusions The PSS reliably differentiates proctological pa-
tients from non-proctological controls. Following interven-
tion, the PSS reliably differentiated therapeutic success from
failure. We find the PSS to be a simple and useful tool in our
clinical routine since it provides an easily obtainable and re-
producible basis for the visit-by-visit assessment of proctolog-
ical patients. The PSS may also be suitable for studies to
measure and compare symptomatic improvement and success
of different therapies in proctology.
Keywords Proctology .Visualscale .Scores .Haemorrhoidal
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Introduction
Proctological complaints are common. Treatment modalities
range from self-treatment with various ointments and suppos-
itories to specialised procto-surgical interventions. Although
no reliable data are available, unquestionable proctological
disorders have a sizeable economic impact. Hence, a simple
tool to identify useful and eliminate less useful therapeutic
options seems desirable.
Proctological symptomatology is of little complexity and
therefore appears particularly suitable for simple comparative
assessment. The idea of a symptom scale was first devised by
Sayfan et al. in studies focussing on the outcome of operative
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therapy of haemorrhoidal disease [1]. The authors used visual
analogue scales (VAS) to measure the severity of five major
anal symptoms (pain, itching, discharge/moisture, bleeding,
prolapse). They were able to demonstrate a significant impact
of the intervention on results. However, the instrument was
never tested on controls and the idea of expanding its use is
not pursued further.
Materials and methods
Following a pilot phase of haphazard sampling of the original
symptom scale [1] among a series of 205 patients presenting
to our proctological outpatient clinic, we found that
Bprolapse^ as scale item was almost never chosen (<5 %).
Although we initially found this to be quite perplexing, we
eventually decided to exclude this item to keep the scale as
simple as possible. The reason for the lack of impact of this
item may be that Bprolapse^ is a symptom pertaining exclu-
sively to a small fraction within the group of patients with
haemorrhoidal disease. On the other hand, the Bproctological
symptom scale^ (PSS) was used on the entire spectrum of
benign proctological disorders.
The PSS therefore comprises four items: anal pain, anal
itching/irritation, anal discharge/moisture, anal bleeding. Pa-
tients are asked to mark the severity they subjectively attribute
to their symptom anywhere along the line on a 0 to 10 scale for
each item separately (Fig. 1). To facilitate the use of the scale
for both patient and clinician, we decided to mark the intervals
from 0 to 10 and not use the classic visual analogue scale
design without such markings. This scale enables the clinician
to calculate the scale value without the use of a ruler. Scale
markings in between whole numbers were rounded up or
down to the nearest whole number. Markings halfway in be-
tween the numbers were rounded up.
To establish the age- and sex-dependent variance
among non-proctological individuals, the PSS was first
tested on unselected hospital staff and patients, who
attended our surgical outpatients department for com-
plaints such as hernias or cholecystitis. One series was
taken among patients of a specialised traumatological-
orthopedic department.
To test the PSS in a proctological setting, we chose unse-
lected patients presenting to our proctological outpatient clin-
ic. Patients were also asked to fill in the standard constipation
[2] and incontinence [3] scores in addition to the PSS.We then
focused on the more defined subgroup of patients with symp-
tomatic haemorrhoidal disease suitable for Barron ligation
within this cohort. At first presentation, the diagnosis was
established and Barron ligations were explained and sug-
gested as therapy. Patients were then supplied with a consent
form and a re-appointment was made for the first treatment.
Patients were asked to fill in the PSS at first presentation and
every ensuing visit. The time interval between the Barron
ligations usually is 4 to 6 weeks.
The sampled PSS data were analysed as follows:
(a) Age- and sex-stratified comparison of scale values of the
non-proctological cohort and the proctological cohort at
first presentation. The relative impact of each scale item
for the overall results was analysed separately by com-
parison of the positive response rates (i.e. item marked
>0) for each item.
(b) Effect of intervention (Barron ligation) on scale values in
the subset of patients with haemorrhoidal disease. This
was done by comparative analysis of the PSS baseline
values (prior to first ligation) with the PSS at the time of
presentation for the second ligation.
(c) Within the same subset of patients with haemorrhoidal
disease the sensitivity of the PSS to detect therapeutic
failure was done by an additional chart review of cases
whose overall scale value got worse following their first
Barron ligation. Their eventual outcome was assessed
following all further ligations.
(d) To find out whether the PSS could in part or entirely be
replaced by the widely used constipation [2] or inconti-
nence scores [3], the three instruments were compared in
100 unselected and consecutive proctological patients. If
patients responded B0^ in either of the scores, the score
was considered as Bblind^ to the patient’s symptomatol-
ogy. Patients scoring B0^ in either of the scores were
therefore dichotomized and the respective PSS response
in this group was analysed.Fig. 1 The proctological symptom scale
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Statistical analyses were done by T test calculation using
SPSS keg1 statistical software (SPSS Inc., Chicago, IL). Sta-
tistical significance was achieved with P<0.05.
Approval for this study was obtained by the responsible
ethic board.
Results
In all, 229 proctological patients were compared to 133 con-
trols. The PSSwas found to significantly differentiate between
both groups (Table 1). Whereas in the control group, the PSS
showed significantly higher values in males; no gender differ-
ence was found in the proctological cohort (Table 2). Also,
PSS values of younger and of older proctological patients did
not vary significantly (Table 3). Positive scale values (i.e.
scale values above B0^) were recorded in 86 % of the patients
for Bitching^, 75 % for Bdischarge^, 68 % for Bpain^, and
52 % for Bbleeding^, reflecting the respective weight of each
item for the PSS. One session of rubber band ligation in the
subgroup of patients with haemorrhoidal disease was reflected
by a significantly improved overall PSS in this group
(Table 4). However, 16 cases within this group registered with
a worse PSS. A case-by-case follow-up of these patients
(Table 5) showed that 14 of the 16 patients eventually ended
up with surgery (or with the advice to have surgery). Among
the 100 patients who in addition to the PSS had the constipa-
tion and incontinence scores analysed 12 % scored B0^ in the
constipation score, 46 % scored B0^ in the incontinence score.
Patients marking B0^ in their constipation score had an
average PSS of 6 (median 5, range 0–16), patients marking
B0^ in their incontinence scores had an average PSS of 10
points (median 7, range 0–28).
Discussion
The proctological symptom scale is a simply structured tool
for the assessment of proctological complaints. It measures the
four cardinal proctological symptoms by visual analogue
scales for each symptom separately. The scale can be used
for every patient visit. Patients need a few seconds to fill it
in; doctors require a few seconds to calculate the scale value.
The scale gives an objective measure of the severity of com-
plaints and of our therapeutic performance. In clinical routine,
the PSS clearly offers a better and more detailed basis for the
evaluation of symptom progress than routine entries found in
most outpatient charts (such as Bimproved^ or Bfeels better^).
The proctological symptom scale is the first instrument to
focus exclusively on anal complaints. It was devised as a
concomitant tool for daily proctological routine. Scores com-
monly used in the coloproctological setting are considerably
more intricate and aim at more complex complaints such as
incontinence and constipation [2–6]. They may incorporate
quality of life issues [3, 4]. The PSS does not replace the
established scores neither is the PSS replaced by the scores.
The PSS reliably differentiates proctological patients from
non-proctological controls. Following intervention, the PSS
reliably differentiated therapeutic success from failure. This
proved significant in our subanalysis of Bearly failures^ fol-
lowing rubber band ligation. The further course eventually led
to therapeutic changes in most cases in this subgroup of pa-
tients. In this context, it is notable that these Bfailures^ were
detected very early in the course of their treatment (after their
first rubber band ligation), which may imply a certain prog-
nostic value of the PSS.










aMaximum scale points: 40
Table 2 Scale point distribution vs. gender in proctological patients
and in controls
Proctological patients P value
Gender Male Female
(n=147) (n=84)




Scale pointsa mean/median (range) 3/2(0–14) 2/2(0–7) 0.01
aMaximum scale points: 40
Table 3 Scale point distribution vs. age in proctological patients
Proctological patients P value
Age (years) ≤50 50+
(n=114) (n=115)
Scale pointsa mean/median (range) 11/10(3–30) 11/10(3–40) 0.755
aMaximum scale points: 40
Table 4 Overall impact of one application of rubber band ligation on
scale values in a cohort of patients with hemorrhoidal disease (n=104)
Baseline First ligation P value
Scale pointsa mean/median (range) 10/9(3–25) 7/6(0–25) <0.001
aMaximum scale points: 40
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We find the PSS to be a simple and useful tool in our
clinical routine since it provides an easily obtainable and re-
producible basis for the visit-by-visit assessment of proctolog-
ical patients. The PSS may also be suitable for studies to
measure and compare symptomatic improvement and success
of different therapies in proctology. This may help to disen-
tangle the plethora of options offered by the industry.
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Table 5 Case-by-case analysis of patients registering worse scale
values following first application of rubber band ligation (n=16)
Baseline First ligation Eventual outcome
M, 31 19 22 Operation
F, 55 6 9 Operation
F, 62 9 15 Operation
M, 61 20 21 Operation
F, 52 10 14 Operation
F, 54 5 7 Operation
F, 71 11 15 Operation
M, 46 5 12 Operation
M, 46 8 9 Operation advised
M, 58 12 15 Operation advised
F, 60 8 15 Operation advised
M, 82 8 10 Operation advised
M, 69 3 5 Operation advised
M, 35 8 10 Operation advised
M, 38 23 33 Improved with further ligations
F, 58 3 9 Improved with further ligations
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